PER 0.00% 8.0¢ percheron therapeutics limited

Ann: ATL1102 Revised Plans accelerate reporting of unblinded data, page-38

  1. 4,103 Posts.
    lightbulb Created with Sketch. 1866
    @arjay
    What they need to do is lose this conservative attitude

    how many times have we the long termers suffered through conservatism

    How long did we sit awaiting Tysabri results that had nothing whatsoever to do with us yet because our CEO in his wisdom linked us to tht trial and it failed we suffered by association

    How many years did we sit on submitting an IND for 1102 with the FDA and now we are paying the price the FDA direction is stalled through the tox study

    Why was the Monkey study carried out for the six months instead of the none months required to move the drug forwards by the FDA

    Why was the early access programme for 1102 derailed because the drug manufacturer being different was unacceptable to the European regulators

    Conservatism i have had a whole boat load of conservatism over the journey

    And where has it ever got us nothing but road blocks

    Like i said read and digest arjay the questions are in there up to this moment i have not seen anyone raise them

    So what do they do arjay they get their A$$es over to the US and seek substantial funding to promote all their marvelous achievements within the pipe line

    Enough said Arjay i could go on but i wont
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.000(0.00%)
Mkt cap ! $72.12M
Open High Low Value Volume
8.1¢ 8.1¢ 7.9¢ $33.53K 416.4K

Buyers (Bids)

No. Vol. Price($)
2 92000 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 65186 3
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.